xAmplificationxAmplification
Neutral

Issue of Convertible Loan Notes

xAmplification
March 12, 2026
about 2 hours ago
Share𝕏inf

Aterian plc (LSE: ATN) has announced the issuance of £150,000 in zero-coupon convertible loan notes (CLNs) maturing on December 31, 2027, to a longstanding shareholder. These notes are mandatorily convertible into ordinary shares at a price of 25 pence per share. Additionally, the subscribers will receive 300,000 warrants, which are exercisable at 32.5 pence with a maturity date of February 15, 2028, and a call feature if the share price exceeds 50 pence for three consecutive trading days. The proceeds from this issuance are earmarked to bolster Aterian's trading operations, particularly in light of a notable increase in the price of China Tantalum Concentrate, which has surged from US$101 per pound to US$212 per metric tonne unit since the end of 2025.

This capital raise comes at a time when Aterian is focused on expanding its portfolio of critical metals projects across Africa, including tantalum and lithium resources. The recent spike in tantalum prices presents a favorable backdrop for the company’s trading initiatives, as highlighted by Executive Chairman Charles Bray. The flexibility provided by the redemption feature of the CLNs allows Aterian to potentially mitigate dilution risks by repaying the notes in cash if operational cash flows remain positive. This strategic move aims to enhance the company's balance sheet while supporting ongoing trading activities, which are crucial for its growth trajectory.

Currently, Aterian's market capitalisation stands at approximately £7.5 million. The issuance of the CLNs, while modest in size, reflects a proactive approach to securing funding amidst a volatile commodity market. As of the latest quarterly report, Aterian had a cash balance of around £1 million, with a quarterly burn rate that suggests a funding runway of approximately 12 months. This capital raise, therefore, not only extends the runway but also provides a buffer against potential operational challenges. However, the reliance on a single shareholder for this funding could raise concerns about the concentration of ownership and influence over company decisions.

In terms of valuation, Aterian's current enterprise value is difficult to ascertain precisely given the recent capital raise and market fluctuations. However, comparing Aterian to direct peers in the tantalum sector, such as Tantalex Resources Corporation (CSE: TXR) and Critical Elements Lithium Corporation (TSXV: CRE), offers some insights. Tantalex, for instance, has a market capitalisation of approximately CAD 10 million, with an enterprise value reflecting its resource base and development stage. Aterian's valuation metrics, particularly in relation to its trading operations and the recent price surge in tantalum, suggest that the market may not fully appreciate the potential upside from its strategic initiatives.

The issuance of convertible loan notes introduces a specific risk related to potential dilution if the notes are converted into shares at maturity. While the redemption feature provides some mitigation, the mandatory conversion at a set price could lead to increased share count and dilution of existing shareholders' equity. Furthermore, the reliance on commodity price fluctuations introduces additional risk; should tantalum prices retract from their current highs, Aterian's trading operations may face pressure, impacting revenue and cash flow.

Looking ahead, the next measurable catalyst for Aterian is the anticipated update on its trading operations and the impact of the recent price movements in tantalum. This update is expected to be disclosed in the upcoming quarterly report, which is likely to provide further insights into how the company plans to leverage the current market conditions to enhance its operational performance.

In conclusion, while the issuance of convertible loan notes represents a strategic move to bolster Aterian's financial position, it is classified as a moderate announcement. The capital raise is not transformative but does provide necessary funding to support ongoing operations amidst rising commodity prices. The potential for dilution remains a concern, and the company's ability to navigate the volatile market for critical metals will be crucial in determining its future valuation and operational success.

← Back to news feed